Zobrazeno 1 - 10
of 4 516
pro vyhledávání: '"Bonten, M"'
Autor:
Hassoun-Kheir, N., van Werkhoven, C. H., Dunning, J., Jaenisch, T., van Beek, J., Bielicki, J., Butler, C., Francois, B., Harbarth, S., Padilla, A. C. Hernandez, Horby, P., Koopmans, M., Lee, J., Rodriguez-Baño, J., Tacconelli, E., Themistocleous, Y., van der Velden, A. W., Bonten, M., Goossens, H., de Kraker, M. E. A.
The increasing threat of emerging infectious diseases and antimicrobial resistance requires more efficient, high-quality research. Perpetual Observational Studies (POS) nested within a clinical research network can improve planning, quality and effic
Externí odkaz:
http://arxiv.org/abs/2208.03992
Autor:
Doua J; Janssen Research and Development, Infectious Diseases and Vaccines, Janssen Pharmaceutica, Beerse, Belgium.; European and Developing Countries Clinical Trials Partnership (EDCTP), Brussels, Belgium., Rodríguez-Baño J; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; Department of Medicine, University of Sevilla and Biomedicine Institute of Sevilla/CSIC, Seville, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Froget R; Inserm Clinical Investigation Center 1435, Dupuytren University Hospital, Limoges, France., Puranam P; Health Sciences North Research Institute, Sudbury, ON, Canada., Go O; Janssen Research and Development, Raritan, NJ, USA., Geurtsen J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., van Rooij S; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Vilken T; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Minoru I; Department of Respiratory Medicine, Okitama Public General Hospital, 2000, Nishi-Otsuka, Kawanishi, Yamagata, Japan., Yasumori I; Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan., Spiessens B; Janssen Research and Development, Infectious Diseases and Vaccines, Janssen Pharmaceutica, Beerse, Belgium., Tacconelli E; Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy., Biehl LM; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50924, Cologne, Germany.; German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany., Thaden JT; Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA., Sarnecki M; Janssen Vaccines, Branch of Cilag GmbH International, Bern, Switzerland. sarnecki.michal@gmail.com., Goossens H; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Poolman J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Bonten M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Ekkelenkamp M; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Infection [Infection] 2024 Jun; Vol. 52 (3), pp. 1073-1085. Date of Electronic Publication: 2024 Jan 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Arconada Nuin E; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Vilken T; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Xavier BB; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.; Department of Medical Microbiology and Infection Control, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Doua J; Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica, Beerse, Belgium., Morrow B; Janssen Research & Development, Raritan, NJ, USA., Geurtsen J; Bacterial Vaccines Discovery & Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Go O; Janssen Research & Development, Raritan, NJ, USA., Spiessens B; Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica, Beerse, Belgium., Sarnecki M; Janssen Vaccines, Branch of Cilag GmbH International, Bern, Switzerland., Poolman J; Bacterial Vaccines Discovery & Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Bonten M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; ECRAID, Utrecht, The Netherlands., Ekkelenkamp M; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands., Lammens C; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Glupczynski Y; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Van Puyvelde S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2142-2151.
Autor:
Zhou H; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Department of Hospital Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Buetti N; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Université Paris-Cité, Paris, France., Pérez-Galera S; Unidad Clínica de Medicina Interna, Hospital Universitario Virgen Macarena, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain., Bravo-Ferrer J; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain., Gutiérrez-Gutiérrez B; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Paniagua-García M; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain., Feifel J; Institute of Statistics, Ulm University, Ulm, Germany., Sauser J; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Kostyanev T; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.; National Food Institute, Technical University of Denmark, Lyngby, Denmark., Canton R; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Tan LK; Research and Development, GlaxoSmithKline, London, UK., Basoulis D; First Department of Internal Medicine, Laiko General Hospital, Athens, Greece., Pintado V; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Roilides E; Faculty of Health Sciences, Hippokration General Hospital of Thessaloniki, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Dragovac G; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Torre-Cisneros J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Departamento de Ciencias Médicas y Quirúrgicas, Servicio de Enfermedades Infecciosas Hospital Universitario Reina Sofía/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba, Córdoba, Spain., Mediç D; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey., Goossens H; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium., Bonten M; Julius Center for Health Sciences and Primary Care and University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Rodriguez-Baño J; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., De Kraker MEA; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2132-2141.
Autor:
Messina NL; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia., Pittet LF; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia; Immunology, Vaccinology, Rheumatology and Infectious Diseases Unit, Geneva and University Hospitals and Faculty of Medicine, Geneva, Switzerland., McDonald E; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Moore C; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Barry S; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Bonten M; Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, the Netherlands; European Clinical Research Alliance on Infectious Diseases, Utrecht, Netherlands., Byrne A; St Vincent's Hospitals, Darlinghurst, New South Wales, Australia; Partners In Health, Socios En Salud, Peru; Thoracic Society of Australia & New Zealand (NSW/ACT Branch), Australia., Campbell J; Exeter Collaboration for Academic Primary Care, University of Exeter Medical School, Exeter, United Kingdom., Croda J; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Mato Grosso do Sul, Brazil; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil., Croda MG; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil., Dalcolmo M; Centro de Referência Professor Hélio Fraga, ENSP/FIOCRUZ (Fundação Oswaldo Cruz), Rio de Janeiro, Brazil., de Almeida E Val FF; Tropical Medicine Foundation Dr Heitor Vieira Dourado, Manaus, Brazil., de Oliveira RD; State University of Mato Grosso do Sul, Dourados, Brazil; Post Graduate Program in Health Sciences, Federal University of Grande Dourados, Dourados, Brazil., Dos Santos G; Centro de Referência Professor Hélio Fraga, ENSP/FIOCRUZ (Fundação Oswaldo Cruz), Rio de Janeiro, Brazil., Douglas MW; Storr Liver Centre, The Westmead Institute for Medical Research, The University of Syndey at Westmead Hospital, Westmead, New South Wales, Australia; Centre for Infectious Diseases and Microbiology, Sydney Infectious Diseases Institute, The University of Sydney at Westmead Hospital, Westmead, New South Wales, Australia., Gardiner K; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Research Operations, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Gwee A; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia; Infectious Diseases, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Jardim BA; Institute of Clinical Research Carlos Borborema, Doctor Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Brazil., Kollmann T; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia., Lacerda MV; Institute of Clinical Research Carlos Borborema, Doctor Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Brazil; Instituto Leônidas & Maria Deane, Oswaldo Cruz Foundation Ministry of Health, Manaus, Brazil; University of Texas Medical Branch, Galveston, TX, USA., Lucas M; Department of Immunology, Pathwest, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia; Department of Immunology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; Department of Immunology, Perth Children's Hospital, Nedlands, Western Australia, Australia; School of Medicine, University of Western Australia, Perth, Western Australia, Australia., Lynn DJ; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Manning L; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia; School of Medicine, University of Western Australia, Perth, Western Australia, Australia; Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Marshall H; The University of Adelaide and the Women's and Children's Health Network, Adelaide, SA, Australia., O'Connell A; Exeter Clinical Trials Unit, University of Exeter, Exeter, United Kingdom., Perrett KP; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia; Population Allergy Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Allergy and Immunology, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Post JJ; Department of Infectious Diseases, Prince of Wales Hospital, Randwick, New South Wales, Australia; School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia., Prat-Aymerich C; Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, the Netherlands; European Clinical Research Alliance on Infectious Diseases, Utrecht, Netherlands., Rocha JL; Helio Fraga Reference Center, Oswaldo Cruz Foundation Ministry of Health, Curicica, Brazil., Rodriguez-Baño J; Division of Infectious Diseases and Microbiology, Department of Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicines Institute of Seville-Consejo Superior de Investigaciones Científicas, Seville, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carloss III, Madrid, Spain., Wadia U; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia; School of Medicine, University of Western Australia, Perth, Western Australia, Australia., Warris A; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom; Department of Infectious Diseases, Great Ormond Street Hospital, London, United Kingdom., Davidson A; Melbourne Children's Trial Centre, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Curtis N; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia; Infectious Diseases, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia. Electronic address: nigel.curtis@rch.org.au.
Publikováno v:
The Journal of infection [J Infect] 2024 Aug 08; Vol. 89 (4), pp. 106245. Date of Electronic Publication: 2024 Aug 08.
Autor:
Colle, L., Kloosterman, F., van Bentum-Puijk, W., Vlooswijk, J., Andremont, A., Ben Hayoun, M., Canoui, E., Chabrol, A., Gamany, N., Lafaurie, M., Lefort, A., Lepeule, R., Louis, Z., Rondinaud, E., Sadou Yayé, H., Sarfati, L., Zarrouk, V., Brossier, C., Carrez, L., Lazarevic, V., Renzi, G., von Dach, E., Cohen Percia, S., Shvartz, R., Lellouche, J., Huttner, B.D., de Lastours, V., Wassenberg, M., Maharshak, N., Mauris, A., Galperine, T., Zanichelli, V., Kapel, N., Bellanger, A., Olearo, F., Duval, X., Armand-Lefevre, L., Carmeli, Y., Bonten, M., Fantin, B., Harbarth, S.
Publikováno v:
In Clinical Microbiology and Infection July 2019 25(7):830-838
Autor:
Cárdenas V; Janssen Research & Development LLC, Spring House, PA, United States. Electronic address: cardenasv@yahoo.com., Le Gars M; Janssen Vaccines & Prevention, Leiden, the Netherlands. Electronic address: Mathieu.legars1@gmail.com., Truyers C; Janssen Research & Development, Beerse Belgium. Electronic address: ctruyers@its.jnj.com., Ruiz-Guiñazú J; Janssen Research & Development, Beerse Belgium. Electronic address: JRuizGui@its.jnj.com., Struyf F; Janssen Research & Development, Beerse Belgium. Electronic address: fstruyf@gmail.com., Colfer A; Janssen Research & Development LLC, Spring House, PA, United States. Electronic address: acolfer@its.jnj.com., Bonten M; Julius Center for Health Services and Primary Care, UMC Utrecht, Utrecht University and European Clinical Alliance on Infectious Diseases, Utrecht, the Netherlands. Electronic address: m.j.m.bonten@umcutrecht.nl., Borobia A; Clinical Pharmacology Department, La Paz University Hospital. School of Medicine, Universidad Autónoma de Madrid, IdiPAZ. CIBERINFECT, Spain. Electronic address: alberto.borobia@salud.madrid.org., Reisinger EC; Rostock University Medical Center, Dept. of Infectious Diseases and Tropical Medicine, Rostock, Germany. Electronic address: emil.reisinger@uni-rostock.de., Kamerling IMC; Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, the Netherlands. Electronic address: idvisser@chdr.nl., Douoguih M; Janssen Vaccines & Prevention, Leiden, the Netherlands. Electronic address: macaya.douoguih@merck.com., Sadoff J; Janssen Vaccines & Prevention, Leiden, the Netherlands. Electronic address: Jerry@Centivax.com.
Publikováno v:
Vaccine [Vaccine] 2024 Jun 11; Vol. 42 (16), pp. 3536-3546. Date of Electronic Publication: 2024 May 04.
Autor:
Pittet LF; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.; Infectious Diseases, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.; Immunology, Vaccinology, Rheumatology, and Infectious Diseases Unit, Department of Paediatrics, Gynaecology and Obsterics, Faculty of Medicine, University of Geneva and University Hospitals of Geneva, Geneva, Switzerland., Messina NL; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia., McDonald E; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Orsini F; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Melbourne Children's Trial Centre, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Barry S; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Bonten M; Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, the Netherlands., Campbell J; Exeter Collaboration for Academic Primary Care, University of Exeter Medical School, Exeter, United Kingdom., Croda J; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil., Croda MG; Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil., Dalcolmo M; Helio Fraga Reference Center, Oswaldo Cruz Foundation Ministry of Health, Curicica, Brazil.; Catholic University, Rio de Janeiro, Brazil., Gardiner K; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Research Operations, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Gwee A; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.; Infectious Diseases, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Jardim B; Institute of Clinical Research Carlos Borborema, Doctor Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Brazil., Lacerda MVG; Institute of Clinical Research Carlos Borborema, Doctor Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Brazil.; Instituto Leônidas & Maria Deane, Oswaldo Cruz Foundation Ministry of Health, Manaus, Brazil.; University of Texas Medical Branch, Galveston, TX, USA., Lucas M; Department of Immunology, Pathwest, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.; Department of Immunology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.; Department of Immunology and General Paediatrics, Perth Children's Hospital, Nedlands, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia., Lynn DJ; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Manning L; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia.; Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Perrett KP; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.; Melbourne Children's Trial Centre, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Allergy and Immunology, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Post JJ; Department of Infectious Diseases, Prince of Wales Hospital, Randwick, New South Wales, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia., Prat-Aymerich C; Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, the Netherlands.; Institut d'Investigació Germans Trias i Pujol, Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Respiratorias, Instituto de Salud Carlos III, Barcelona, Spain., Richmond PC; Department of Immunology and General Paediatrics, Perth Children's Hospital, Nedlands, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia., Rocha JL; Helio Fraga Reference Center, Oswaldo Cruz Foundation Ministry of Health, Curicica, Brazil., Rodriguez-Baño J; Division of Infectious Diseases and Microbiology, Department of Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicines Institute of Seville-Consejo Superior de Investigaciones Científicas, Seville, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carloss III, Madrid, Spain., Warris A; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom., Wood NJ; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Sydney Children's Hospital Network, Westmead, New South Wales, Australia.; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Disease, Westmead, New South Wales, Australia., Davidson A; Melbourne Children's Trial Centre, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Curtis N; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.; Infectious Diseases, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2024 May 13; Vol. 72, pp. 102616. Date of Electronic Publication: 2024 May 13 (Print Publication: 2024).
Autor:
Kingsley J; Centricity Research (formerly IACT Health), Columbus, Georgia, USA., Kumarasamy N; VHS Infectious Diseases Medical Centre, Chennai Antiviral Research and Treatment Clinical Research Site, Chennai, India., Abrishamian L; South Bay Clinical Research Institute, Redondo Beach, California, USA., Bonten M; Department of Epidemiology & Health Economics, University Medical Center Utrecht, Utrecht, The Netherlands., Igbinadolor A; Monroe Biomedical Research, Monroe, North Carolina, USA., Mekebeb-Reuter M; Excellentis Clinical Trial Consultants, George, South Africa., Rosa J; Clinresco Centres, Gauteng, South Africa., Solai Elango D; Novartis Global Health, Global Drug Development, Hyderabad, India., Lopez P; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Fustier P; Molecular Partners AG, Zurich-Schlieren, Switzerland., Goncalves S; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Knutson CG; Novartis Global Health, Biomedical Research, Cambridge, Massachusetts, USA., Kukkaro P; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Legenne P; Molecular Partners AG, Zurich-Schlieren, Switzerland., Ramanathan K; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Rao S; Novartis Global Health, Global Drug Development, East Hanover, New Jersey, USA., Reshetnyak E; Novartis Global Health, Global Drug Development, East Hanover, New Jersey, USA., Stavropoulou V; Molecular Partners AG, Zurich-Schlieren, Switzerland., Stojcheva N; Molecular Partners AG, Zurich-Schlieren, Switzerland., Stumpp MT; Molecular Partners AG, Zurich-Schlieren, Switzerland., Tietz A; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Soergel M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Chandra R; Novartis Global Health, Global Drug Development, East Hanover, New Jersey, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 May 03; Vol. 11 (6), pp. ofae233. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).